Correlations between antral follicle count and ultrasonographic ovarian parameters and clinical variables and outcomes in IVF cycles

Gynecological Endocrinology

Volumn 28, Issue 6, 2012, Pages 432-435

  Ben Haroush, Avi ^a,b   Farhi, Jacob ^a   Zahalka, Yasmin ^a   Sapir, Onit ^a   Meizner, Israel ^a   Fisch, Benjamin ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Helen Schneider Hospital for Women   (Israel)

Author keywords

Antral follicle count; IVF; Ovarian volume

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ANTRAL FOLLICLE COUNT; ARTICLE; BODY MASS; CELL COUNT; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OOCYTE MATURATION; OOCYTE RETRIEVAL; ORAL CONTRACEPTION; OVARY FOLLICLE; OVARY FUNCTION; OVARY VOLUME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; CELL COUNT; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; MENSTRUAL CYCLE; MIDDLE AGED; OVARIAN FOLLICLE; OVARY; OVULATION INDUCTION; PREGNANCY; PROGNOSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 84861026701     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.634935     Document Type: Article

References (19)

1. Gougeon A, Ecochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles: Increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod 1994;50:653-663. (Pubitemid 24058526)
2. Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW, te Velde ER. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999;72:845-851.
3. Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998;69:505-510.
4. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: A prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-336. (Pubitemid 34083557)
5. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718. (Pubitemid 44605509)
6. Kwee J, Elting ME, Schats R, McDonnell J, Lambalk CB. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization. Reprod Biol Endocrinol 2007;15:5-9.
7. Staessen C, Camus M, Bollen N, Devroey P, Van Steirteghem AC. The relationship between embryo quality and the occurrence of multiple pregnancies. Fertil Steril 1992;57:626-630.
8. Erdem A, Erdem M, Biberoglu K, Hayit O, Arslan M, Gursoy R. Age-related changes in ovarian volume, antral follicle counts and basal FSH in women with normal reproductive health. J Reprod Med 2002;47:835-839.
9. Erdem M, Erdem A, Biberoglu K, Arslan M. Age-related changes in ovarian volume, antral follicle counts and basal follicle stimulating hormone levels: Comparison between fertile and infertile women. Gynecol Endocrinol 2003;17:199-205. (Pubitemid 36760720)
10. Su HI, Sammel MD, Freeman EW, Lin H, DeBlasis T, Gracia CR. Body size affects measures of ovarian reserve in late reproductive age women. Menopause 2008;15:857-861.
11. Yu Ng EH, Chi Wai Chan C, Tang OS, Shu Biu Yeung W, Chung Ho P. Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation. Hum Reprod 2004;19:2811-2815. (Pubitemid 40028952)
12. Cedrin-Durnerin I, Bstandig B, Parneix I, Bied-Damon V, Avril C, Decanter C, Hugues JN. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod 2007;22:109-116. (Pubitemid 44942673)
13. Gougeon A. Human ovarian follicular development: From activation of resting follicles to preovulatory maturation. Ann Endocrinol (Paris) 2010;71:132-143.
14. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-130.
15. Cook CL, Siow Y, Taylor S, Fallat ME. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000;73:859-861. (Pubitemid 30154132)
16. Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril 2008;90:395-400.
17. Panidis D, Georgopoulos N, Piouka A, Katsikis I, Saltamavros AD, Decavalas G, Diamanti-Kandarakis E. The impact of oral contraceptives and metformin on anti-Mullerian hormone serum levels in women with polycystic ovary syndrome. Gynecol Endocrinol 2011;27:1-6.
18. Mohamed KA, Davies WA, Lashen H. Antimullerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate. Fertil Steril 2006;86:1515-1517. (Pubitemid 44602035)
19. Broer SL, Mol B, Dolleman M, Fauser BC, Broekmans FJ. The role of anti-Mullerian hormone assessment in assisted reproductive technology outcome. Curr Opin Obstet Gynecol 2010;22:193-201.